Warner Chilcott Logo

Warner Chilcott to Present at the 31st Annual J.P. Morgan Healthcare Conference

| Source: Warner Chilcott

DUBLIN, Ireland, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to speak at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8th at 7:30 a.m. PST (10:30 a.m. EST).

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-G

Rochelle Fuhrmann
Investor Relations